case report aspiration anesthesia semaglutide 2023 Anesthetic Considerations for Patients Taking Glucagon-Like Peptide-1 Agonists Brasil - Risk of pulmonary
Description
Due to the popularity of these drugs, the commercial manufacturers have been unable to keep up with the demand
In individuals with obesity and diabetes, the incretin effect is diminished, contributing to poor glucose tolerance
10.3389/fcimb.2022.853771 [DOI] [PMC free article] [PubMed] [Google Scholar] 7
Youre not aloneand were here to help you find lasting relief
As with other GLP-1 medicines, people with: A history of severe gastrointestinal disease Pancreatitis Significant kidney or liver issues should only use GLP-1 treatments under close clinical monitoring
Several physiological and behavioural factors may explain weight gain during Ozempic therapy, even though the medication typically promotes weight loss
